Research and Development Strategy done By Apple

Apple continued to develop the new product and technologies and to enhance new existing products that expand the range of its product offerings and intellectual property through licensing and acquisition of third - party business and technology.

Apple's Organizational Activity analysis

The company's strategy included expanding its distribution network to effectively reach more customers and provide them with a high -quality sales and post-sales support experience.the company was there fore uniquely positioned to offer superior and well - integrated digital life -  style and productivity solutions.

To remain competitive ,Apple believed that increased investment in research and development ,marketing and advertising was necessary to maintain or expand its position in these markets.

Apple utilized a variety of direct and in direct distribution channels including its retail stores , online, stores and  direct sales force , as well as third party cellular network carriers ,whole-sellers,retailers and value added re- sellers . The company believed that sales of its innovative and differentiated products were enhanced by knowledgeable sales person who could convey  the value of hard ware,soft ware peripheral integration.

Corporate Culture of Apple Inc.

The company's business strategy leverage its unique ability to design and develop its own operating system,hardware,application soft ware and services to provide its customers new products and solutions with superior ease of use, seamless integration ,and innovative industrial design.the company believed continual investment in research development and was critical to the development and enhancement of technologies.

the company also worked to support a community for the development of third - party software and hard ware products and digital content that complement the company's offerings.

External Summary for Apple Inc.

Apple Inc.further believed providing direct contact with the targeted customer was an effective way to demonstrate the advantage of its product over those of the competitors,and that providing a high quality sales  and after sales support experiences use critical to attracting -and retaining existing customer .At this time Apple was receiving a number of offers to acquire the company.Many of the company's executives advocate Apple merging with another company.

Industry Environment for Apple Inc.

The early success of Apple Inc.was attributed largely to marketing and technological innovation.In the high growth industry Apple grew quickly,staying ahead of competitors by contributing key products that stimulate the development of software for the computer.

Even with enormous competition ,Apple revenues continues to grow at an unprecedented rate,reaching $583.3 million by fiscal 1982.Apple kept the architecture of the Macintosh property.That is,it could not be cloned like the "open system".This allowed the company to charge a premium for its distinctive "User Friendly " featurers.

General Environment for Apple Inc.

On April 1,1976, Apple Inc. was formed as a partnership.The company was committed to bring the best user experience to its customers through its innovative product.Apple platform by providing a high level of integration and support services, as well as product expertise.

beximco Pharma: Quality

Beximco pharma aspires to become a nationally admired and globally reputed generic pharmaceutical company,committed to enhancing human health and life with strong reverse engineering capability.

BPL focus principally on developing high quality generic formulations,matching the profile of innovator products.BPL also focus on simplifying manufacturing processes and improving cost efficiency.

their growing innovation is evident from successful launching of a number of advanced formulations like multi-layer - tablets,sustained release formulations, dispersal tablets,melt-in mouth tablets, chew able vitamins etc.

in propreitory research,we conducted collaborative research with Ciba speciality chemicals of Switzerland with rheir R & D team has successfully developed a range of CFC-Free HFA MDIs.

In addition ,they are also developing a number of APIs to ensure availability of raw materials across the range of therapeutic classes.

Their capability to produce hi-tech ,specialized niche products as well as drug delivery systems have been 

our core strength to transform BPL into an innovation -driven generic drug company.

Beximco Pharmaceuticals LTD.is a leading company in Bangladesh.To compete with other companies in the industry ,BPL uses several contemporary methods and techniques.

Mass production of a mature product with known characteristics and a stable technology was the basis of traditional cost accounting models.